Cargando…
Pathology of COVID-19-associated acute kidney injury
Acute kidney injury (AKI) is common among hospitalized patients with coronavirus disease 2019 (COVID-19), with the occurrence of AKI ranging from 0.5% to 80%. An improved knowledge of the pathology of AKI in COVID-19 is crucial to mitigate and manage AKI and to improve the survival of patients who d...
Autores principales: | Sharma, Purva, Ng, Jia H, Bijol, Vanesa, Jhaveri, Kenar D, Wanchoo, Rimda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929005/ https://www.ncbi.nlm.nih.gov/pubmed/33796284 http://dx.doi.org/10.1093/ckj/sfab003 |
Ejemplares similares
-
Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review
por: Kitchlu, Abhijat, et al.
Publicado: (2021) -
Acute tubulointerstitial nephritis and COVID-19
por: Ng, Jia H, et al.
Publicado: (2021) -
Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19
por: Ng, Jia H., et al.
Publicado: (2020) -
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury
por: Ng, Jia H., et al.
Publicado: (2021) -
Anaplastic lymphoma kinase inhibitors and their effect on the kidney
por: Bonilla, Marco, et al.
Publicado: (2022)